Doctor insights on:
Yes and No: Certain genetic conditions may predispose someone to malignant melanoma. But there are certainly things that can be done to boost one's immune system to fight cancers. And those with irregular moles should be seen at least yearly by their doctor or dermatologist to remove suspicious moles. Therefore, preventing a metastatic process. ...Read moreSee 2 more doctor answers
Diagnoged with cutaneous tcell lymphoma nhl.Treated with eletron beam.Interferon, gemcitabine, anthracycline, etoposide, procarbazine.Nodules over body .?
Genetic component?: There could be genetic component to a squamous cell cancer, although the exact implications on treatment aren't known. Obviously if there is a strong family history of cancers, or if it strikes someone who is young and/or a non smoker/drinker i would suspect a strong genetic contribution. Without more details, it is hard to say with any certainty. ...Read moreSee 1 more doctor answer
A little bit: Yes, but not a great deal. The good news is that surveillance for any skin cancer is the same. Examine your own skin regularly, and keep your scheduled appointments with your doctor or dermatologist. Notify them if you see any lesions which are concerning for skin cancer. Best wishes! ...Read moreSee 2 more doctor answers
Aggressive cancer: Melanoma develops from melanocytes cells of the lower layers in the skin. These cells produce pigments and the color of skin. When they form into cancer it can grow radially and deeply which can be dangerous as it can subsequently spread to other areas of the body. There are genetic predispositions as well as ultraviolet radiation exposure and sunburns are risk factors. ...Read moreSee 4 more doctor answers
Yes, for Stage 4: Nexavar, or sorafenib, is used to treat advanced, unresectable hepatocellular carcinoma. It is also used to treat patients with advanced kidney cancer. This drug is a multikinase inhibitor and works by decreasing tumor growth and replication, by inhibiting the formation of blood vessels that tumors rely on to get nourishment. This is not a curative treatment, prolonging survival on average 7 mo. ...Read more
Hepatocellular carcinoma.All spleen and partial liver resection.Later,secondary systemic cancer metastasis.any targeted therapy or immunotherapy?
Yes, for both: Hepatocellular Carcinoma is commonly treated with Sorafenib which is a type of targeted therapy. This is a good choice of treatment in case you have not yet received this drug. Immunotherapy using PD-1 inhibitors has also shown some modest evidence of benefit although it is not yet FDA approved for this indication. Ask your oncologist to guide your treatment further. ...Read more
Stage 2B IDC breast cancer, her2+/ER/PR+Neoadjuvant taxol, (paclitaxel)A/C,lumpectomy,rads, lymphovascular invasion. What does this mean for prognosis & follow up?
Prognosis fair: Stage IIb breast cancer is usually palpable at 2-5 cm. and at time of procedure to remove lesion, sentinel nodes are + suggesting axillary dissection and reason for neoadjuvant therapy. Lymphovascular invasion increases chance for recurrence. With Her2+ Herceptin (trastuzumab) with chemo should be used and PET/CAT needed to assure met foci not missed in distal organs. Carful follow up needed. ...Read more
Taxonomy of: Malignancy used to derive from embyonal cells of origin. All ectoderm and endoderm linings were cancers, and tended to spread to nodes. All mesodermal origin tissues were sarcomas, and tended to bllod borne mets. Bone marrow and lymphatics were mesodermally derives, andformerly were called "lymphosarcoma". Frankly, historical interset only, not helpful. Burkitt is linked to ebstein barr virus. ...Read moreSee 3 more doctor answers